83 related articles for article (PubMed ID: 31513909)
1. Leukotriene B4 at low dosage negates the catabolic effect of prostaglandin E2 in human patellar tendon fibroblasts.
Thampatty BP; Im HJ; Wang JH
Gene; 2006 May; 372():103-9. PubMed ID: 16488093
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E
Gadelha LR; Costa MJB; Abreu JPA; Venancio LPR; Fabres-Klein MH; Klein RC; Lima JB; Araújo-Santos T
Prostaglandins Other Lipid Mediat; 2024 Jun; 172():106820. PubMed ID: 38346573
[TBL] [Abstract][Full Text] [Related]
3. Aspirin-exacerbated asthma.
Varghese M; Lockey RF
Allergy Asthma Clin Immunol; 2008 Jun; 4(2):75-83. PubMed ID: 20525128
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in Human
Reigada-Rivera ML; Lozano CS; Rodilla EM; García-Sánchez A; García-Solaesa V; Toledano FL; González ID; Isidoro-García M
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456412
[TBL] [Abstract][Full Text] [Related]
5. Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features.
Rama TA; Morgado JM; Henriques A; Escribano L; Alvarez-Twose I; Sanchez-Muñoz L; Moreira A; Romão J; Órfão A; Matito A
Clin Transl Allergy; 2022 Mar; 12(3):e12132. PubMed ID: 35344302
[TBL] [Abstract][Full Text] [Related]
6. Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease.
Eid R; Yan CH; Stevens W; Doherty TA; Borish L
J Allergy Clin Immunol; 2021 Aug; 148(2):309-318. PubMed ID: 34364539
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics of NSAID-induced Blended Reaction.
Hur GY; Park HS
Allergy Asthma Immunol Res; 2021 Mar; 13(2):171-172. PubMed ID: 33474853
[No Abstract] [Full Text] [Related]
8. Cellular interactions in aspirin-exacerbated respiratory disease.
Badrani JH; Doherty TA
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):65-70. PubMed ID: 33306487
[TBL] [Abstract][Full Text] [Related]
9. The Biology of Prostaglandins and Their Role as a Target for Allergic Airway Disease Therapy.
Lee K; Lee SH; Kim TH
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182661
[TBL] [Abstract][Full Text] [Related]
10. Factors driving the aspirin exacerbated respiratory disease phenotype.
Steinke JW; Borish L
Am J Rhinol Allergy; 2015; 29(1):35-40. PubMed ID: 25590316
[TBL] [Abstract][Full Text] [Related]
11. Aspirin intolerance and nasal polyposis.
Picado C
Curr Allergy Asthma Rep; 2002 Nov; 2(6):488-93. PubMed ID: 12428645
[TBL] [Abstract][Full Text] [Related]
12. Suppression of aspirin-mediated eosinophil activation by prostaglandin E
Pal K; Ramsden M; Shim YM; Borish L; Payne SC; Steinke JW
Ann Allergy Asthma Immunol; 2019 Nov; 123(5):503-506. PubMed ID: 31513909
[TBL] [Abstract][Full Text] [Related]
13. Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease.
Steinke JW; Negri J; Liu L; Payne SC; Borish L
J Immunol; 2014 Jul; 193(1):41-7. PubMed ID: 24890720
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis.
Picado C; Mullol J; Roca-Ferrer J
J Allergy Clin Immunol; 2023 Feb; 151(2):310-313. PubMed ID: 36126795
[TBL] [Abstract][Full Text] [Related]
15. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
